Pramodini Medicare
add_icon

Pramodini Medicare IPO

IPO Open Now
₹2,64,000
Bidding Dates 12 Aug, 26 -14 Aug, 26
Min Investment ₹2,64,000
Lot Size1,200
Price Range ₹110 – ₹118
Issue Size ₹69.04 Cr.
Download Doc
IPO Timeline
IPO Offer Start
12 Aug,26
IPO Offer Ends
14 Aug,26
Allotment Finalisation
17 Aug,26
Refund Initiation
18 Aug,26
Listing of Shares
19 Aug,26

IPO Analysis

Strengths
Strenghts

The company operates through 16 diagnostic centres across 7 states (Uttar Pradesh, Andhra Pradesh, Karnataka, West Bengal, Haryana/NCR Delhi, Madhya Pradesh and Kerala) and 14 cities in India, providing a strong operational footprint and reputation for quality diagnostic services.

Strenghts

The company operates across four key models: Public Private Partnership (7 centres), Private Private Partnership (3 centres), Strategic Partnership with PSUs (4 centres), and Private Centres (2 centres), providing diversified revenue streams and risk mitigation.

Strenghts

The company deploys advanced equipment including 8 CT machines, 7 MRI machines, 20 X-ray machines, 1 PET CT, and maintains relationships with equipment vendors for favorable procurement terms and preferred vendor status.

Risks
Risk

The company derives 54.19% of revenue from Public Private Partnership arrangements with government authorities as of FY 2025-26. Any non-renewal, modification, or termination of MOUs, or delays in payments from government authorities, may materially affect business operations and financial condition.

Risk

The company generates 97.05% of revenue from radiology services as of FY 2025-26, creating significant exposure to capital-intensive equipment requirements and regulatory compliance risks. This concentration exposes the company to disproportionate impact from disruptions or market shifts in the radiology domain.

Risk

The company derives 61.90% of revenue from Andhra Pradesh as of FY 2025-26. Any regional economic slowdown, political unrest, or reduced demand in this state could adversely affect business operations and financial performance.

Objectives

The company intends to purchase and install medical equipments across existing diagnostic centres in Hubli, Manjeri, and Vijayawada, and establish a new diagnostic centre in Bangalore to expand capacity, improve service efficiency, and strengthen brand presence.

The company plans to evaluate inorganic growth opportunities through mergers and acquisitions to expand into new geographies, add service offerings, and consolidate market position, along with meeting general corporate expenses in the ordinary course of business.

Yearly Financial Results

Annual Financials
Mar 2024
Mar 2025
Mar 2026
Revenue
35.23
38.24
62.29
Expenses
25.72
22.80
40.08
Other Income
0.56
0.31
1.09
Total Revenue
35.79
38.55
63.38
Profit Before Tax
10.08
15.75
23.30
Net Profit
6.93
11.03
17.38

Balance Sheet

Balance Sheet
Mar 2024
Mar 2025
Mar 2026
Total Assets
48.78
56.45
93.62
Current Assets
22.39
19.34
33.07
Fixed Assets
26.39
37.11
60.55
Total Equity & Liabilities
48.78
56.45
93.62
Total Liabilities
24.03
20.67
40.46
Current Liabilities
17.47
12.27
26.30
Non Current Liabilities
6.56
8.40
14.17
Total Equity
24.75
35.77
53.15

Cash Flow

Cash Flow
Mar 2024
Mar 2025
Mar 2026
Net Cash Flow
-2.34
5.07
0.50
Investing Activities
-1.38
-14.66
-30.63
Operating Activities
9.85
22.12
25.39
Financing Activities
-10.81
-2.39
5.73

About Pramodini Medicare

The company is a diagnostic service provider in India offering technology-enabled diagnostic services including radiology, clinical laboratory and nuclear medicine services to public hospitals, private hospitals, PSUs and medical colleges across tier I, II and III cities. The company operates through four key models: Public Private Partnership, Private Private Partnership,...more
Managing DirectorDr. Chalasani Kuldeep Kumar